Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature

Katherine A. Rybinski(Morphotek (United States)), Yuhong Zhou(University of Electronic Science and Technology of China), Jason Wustner(Morphotek (United States)), Brian Drozdowski(Morphotek (United States)), Shawn Fernando(Morphotek (United States)), Nicholas C. Nicolaides(Johns Hopkins University), Keiji Furuuchi(Penn Presbyterian Medical Center), Qimin Chao(Morphotek (United States)), Brad Kline(University of California, San Francisco), Earl F. Albone(Morphotek (United States)), Hongxia Z. Imtiyaz(Cancer Research Institute), Luigi Grasso(Morphotek (United States)), James Fulmer(Morphotek (United States)), Marianne Henry(Morphotek (United States)), Jianmin Lin, Barrie Mittica(Morphotek (United States))
Oncotarget
July 4, 2015
Cited by 48


Related Papers